FAST NEWS: WuXi AppTec Q1 Profit Doubles on Strong Chemical Business
The latest: Pharmaceutical services outsourcing company WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) reported its revenue rose 71.2% to 8.47 billion yuan ($1.29 billion) in the first quarter, while its operating profit rose…
RELATED ARTICLES
-
WuXi Biologics hatches new baby with ADC drug unit IPO
2269.HK
-
Potential U.S. targeting casts shadow over WuXi AppTec family
2359.HK 603259.SHG
-
WuXi Bio prescribes share buyback to relieve revenue pain
2269.HK
-
FAST NEWS: JPMorgan boosts WuXi AppTec stake
2359.HK 603259.SHG
-
FAST NEWS: U.S. investment firm boosts WuXi AppTec stake
2359.HK 603259.SHG
-
FAST NEWS: BlackRock boosts stake in battered WuXi AppTec
2359.HK 603259.SHG
-
FAST NEWS: WuXi Biologics boosts new projects target
2269.HK
Discover hidden China stock gems in our weekly newsletter